CHESAPEAKE ASSET MANAGEMENT LLC
Position in RXRX — Recursion Pharmaceuticals, Inc.
CIK 1079397
NEW YORK, NY
Position in RXRX
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$11,982
+$1,959 QoQ
Shares Held
3,265
0.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#282
of 340 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RXRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026CHESAPEAKE ASSET MANAGEMENT LLC holds $41,441 across 4 Biotechnology names. RXRX ranks #2 (28.9% of the industry book) .
All Filings in RXRX
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $11,982 | 3,265 | Shares | Sole | 2026-08-04 | |
| 2026-03-31 | $10,023 | 3,265 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $13,353 | 3,265 | Shares | Sole | 2026-01-08 | |
| 2025-09-30 | $15,933 | 3,265 | Shares | Sole | 2025-10-17 | |
| 2025-06-30 | $11,460 | 2,265 | Shares | Sole | 2025-10-15 | |
| 2025-03-31 | $11,981 | 2,265 | Shares | Sole | 2026-01-05 | |
| 2024-12-31 | $23,910 | 3,537 | Shares | Sole | 2026-01-05 | |
| No filing history on record for this holder in this stock. | ||||||